
NYSE:EL
This summary was created by AI, based on 1 opinions in the last 12 months.
Estee Lauder, represented by the symbol EL-N, has garnered favorable reviews from analysts, particularly highlighted by its significant price increase of 68% since June 10, 2025, marking it as a Top Pick. The company's technical indicators, coupled with strong fundamentals, provided a compelling case for investment during this period. Investors have expressed their satisfaction with the returns achieved thus far; however, there is a sense among some experts that the stock may be nearing its peak potential. The consensus is that while the stock has performed exceptionally well, one should carefully assess future growth prospects as it may have reached a plateau in its upward trajectory. Overall, Estee Lauder remains an attractive option for investors who appreciate its recent performance but should weigh the outlook cautiously before making further decisions.
It's been heavily shorted, but today's FDA approval of Pfizer gave it a boast. It's a play on cross-border travel (prominent in duty-free airports). No wonder it jumped over 1% today.
Hit fresh highs today Is up nearly 20% this year. She loves their deal with Target.